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Basonuclin (Bnc1), a cell-type-specific ribosomal RNA (rRNA) gene regulator, is expressed mainly in keratinocytes of stratified
epithelium and gametogenic cells of testis and ovary. Previously, basonuclin was shown in vitro to interact with rRNA gene
(rDNA) promoter at three highly conserved sites. Basonuclin’s high affinity binding site overlaps with the binding site of
a dedicated and ubiquitous Pol I transcription regulator, UBF, suggesting that their binding might interfere with each other if
they bind to the same promoter. Knocking-down basonuclin in mouse oocytes eliminated approximately one quarter of RNA
polymerase I (Pol I) transcription foci, without affecting the BrU incorporation of the remaining ones, suggesting that
basonuclin might regulate a subset of rDNA. Here we show, via chromatin immunoprecipitation (ChIP), that basonuclin is
associated with rDNA promoters in HaCaT cells, a spontaneously established human keratinocyte line. Immunoprecipitation
data suggest that basonuclin is in a complex that also contains the subunits of Pol I (RPA194, RPA116), but not UBF. Knocking-
down basonuclin in HaCaT cells partially impairs the association of RPA194 to rDNA promoter, but not that of UBF. Basonuclin-
deficiency also reduces the amount of 47S pre-rRNA, but this effect can be seen only after cell-proliferation related rRNA
synthesis has subsided at a higher cell density. DNA sequence of basonuclin-bound rDNA promoters shows single nucleotide
polymorphisms (SNPs) that differ from those associated with UBF-bound promoters, suggesting that basonuclin and UBF
interact with different subsets of promoters. In conclusion, our results demonstrate basonuclin’s functional association with
rDNA promoters and its interaction with Pol I in vivo. Our data also suggest that basonuclin-Pol I complex transcribes a subset
of rDNA.
Citation: Zhang S, Wang J, Tseng H (2007) Basonuclin Regulates a Subset of Ribosomal RNA Genes in HaCaT Cells. PLoS ONE 2(9): e902. doi:10.1371/
journal.pone.0000902
INTRODUCTION
Basonuclin (Bnc1) is a zinc finger transcription factor expressed
mainly in the keratinocytes of stratified epithelium and the
reproductive germ cells of testis and ovary [1,2]. Basonuclin is
localized at the rDNA clusters on acrocentric chromosomes during
mitosis [3], a typical behavior of Pol I-associated factors.
Consistent with this localization, basonuclin’s zinc fingers interact
with rDNA promoter at three highly conserved binding sites [3–5].
No interaction was detected between basonuclin and beta-satellite
DNA, which is a repetitive sequence also localized near the rDNA
clusters on the short arms of human acrocentric chromosomes [3].
These results suggest that basonuclin’s interaction with rDNA
promoter is specific and not related to the repetitive nature of the
rDNA array. Basonuclin stimulates transcription from a co-
transfected rDNA promoter and basonuclin zinc fingers can act as
a dominant-negative agent to inhibit Pol I transcription in oocytes
[5]. Most interestingly, when basonuclin was knocked-down in
mouse oocytes, the number of Pol I transcription foci were
reduced, and the incorporation of BrU by the remaining foci was
not affected [6]. This observation suggests that basonuclin
regulates a subset of rDNA. Another intriguing issue is the
relationship of basonuclin and the ubiquitous Pol I regulator UBF,
which are co-localized on the same chromosomal loci in mitotic
keratinocytes [3]. However, DNase I footprints of basonuclin and
UBF overlap [3–5], which led to our question whether they
interact with the same promoter molecule [3,5].
Here we describe a study of basonuclin’s interaction with rDNA
promoters in the HaCaT cells, a spontaneous established human
keratinocyte cell line [7]. To validate basonuclin’s role in rRNA
transcription, we also established a basonuclin knock-down model
in the HaCaT cells. Our data lead us to propose some features of
basonuclin’s role in regulation of rRNA synthesis.
RESULTS
Basonuclin interacted with rDNA promoter in HaCaT
cells
Previously, in vitro DNase I foot-printing detected highly-
conserved basonuclin–binding sites within the human and mouse
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performed to examine basonuclin’s association with rDNA
promoter in HaCaT cells. HaCaT cells retained characteristics
of proliferative basal keratinocytes [7], where basonuclin was
highly expressed [8]. To precipitate basonuclin-associated chro-
matin, we used an affinity-purified anti-human-basonuclin anti-
body (alpha-hB34), which was raised against the full-length
basonuclin and shown to detect basonuclin in Western blot as
well as in immunocytochemistry [3]. The alpha-hB34 antibody
precipitated from HaCaT cell extract a protein with molecular
weight identical to that of basonuclin (i.e., 120k)(Fig. 1A) [3,9,10].
The amount of antibody used was sufficient to remove all soluble
basonuclin (Fig. 1A), suggesting a quantitative precipitation. We
used the up-stream binding factor (UBF), a ubiquitous Pol I
transcription factor, as a positive control for interaction with
rDNA promoter. The negative controls were Wilms’ tumor
protein (WT-1), a zinc finger transcription factor for Pol II
[11,12], and the normal rabbit IgG. To detect basonuclin’s
association with rDNA promoter, chromatin was twice pre-
cipitated by individual antibodies. The precipitated chromatin
DNA was ligated to PCR primers and amplified. The amplified
DNA was subjected to a southern analysis, which showed that only
DNA cross-linked with basonuclin and UBF contained the rDNA
promoter sequence (Fig. 1B). This analysis provided the first
evidence of basonuclin’s association with rDNA promoter in vivo.
The southern analysis also showed that basonuclin- and UBF-
associated rDNA promoter fragments ranged between 0.2–0.4 kb
(i.e., the resolution of the ChIP assay) (Fig. 1B). This fragment
length was sufficient to resolve basonuclin/DNA interaction with
various regions of the rDNA transcription unit. PCR primers were
designed to examine three regions of rDNA, i.e., the promoter, the
internally transcribed spacer (ITS) and the intergenic spacer (IGS).
Most basonuclin appeared to associate with the promoter, much
less with the ITS and none with the IGS (Fig. 1C). UBF, on the
other hand, associated equally with the promoter and ITS, as
shown previously [13].
To examine if basonuclin’s association with rDNA promoter
was regulated by extracellular signals, we performed ChIP assays
with HaCaT cells cultured with or without serum for 24 h.
Western analysis showed that precipitable basonuclin was reduced
in the absence of serum (Fig. 1D). A greater reduction was
observed for promoter associated with basonuclin (Fig. 1E).
Within the same cell extract, the amount of UBF-associated rDNA
promoter was only slightly reduced. This result suggested that
promoter interactions of basonuclin and UBF were differentially
regulated.
Knocking-down basonuclin in HaCaT cells by siRNA
To investigate if basonuclin’s interaction with rDNA promoter was
functional, we knocked-down basonuclin mRNA in HaCaT cells
using small interfering RNA (siRNA). We tested two types of
siRNA reagents, regular and stealth (Invitrogen), designated
respectively as siBnc1-r and siBnc1-s. Each targeting siRNA was
matched with a negative control siRNA (siCb-r, and siCb-s), which
had the same nucleotide composition of the targeting siRNA but
a scrambled sequence. The efficiency of the targeting siRNAs was
evaluated by transfecting them into HaCaT cells and monitoring
their effect on basonuclin mRNA as compared with the negative
controls. The stealth siRNA had lower cytotoxicity and was the
more effective, hence was used for all experiments described here.
Transfecting siBnc1-s into HaCaT cells decreased basonuclin
mRNA level, which reached a minimum at 12 h post transfection
but recovered somewhat at 24 h (Fig. 2A, RT-PCR) and
maintained at a low level during the rest of the experiment. By
Western blot, we observed an apparent decrease in basonuclin
protein at 12 h post transfection, which fell to less than 5% of the
control at 24 h and remained at this level during the observation
period (up to 48 h post transfection) (Fig. 2A, Western). The
reduction in basonuclin was also observed by immunocytochem-
ical staining of transfected cells (Fig. 2B). In the majority of
HaCaT cells (.90%), nuclear basonuclin was barely detectable
24 h post transfection of siBnc1-s (Fig. 2B, siBnc1 column). The
Figure 1. Basonuclin interacts with rDNA promoter in vivo. A, Western
analyses of immunoprecipitated proteins from HaCaT cell lysate. The IP
antibodies are shown above the Western blot; B, anti-basonuclin (alpha-
hB34), U, anti-UBF, W, anti-WT protein, and G, IgG from a naive rabbit.
The detecting antibodies are indicated on the left. The target proteins
were monitored in both the pellet and supernatant. Note that no cross-
reactivity was observed. B, The resolution of the ChIP assay was
assessed by a Southern analysis. A primer was ligated to the
immunoprecipitated DNA, which was then amplified by PCR. The
amplified DNA was separated by agarose electrophoresis and visualized
by ethidium bromide (EtBr). The DNA was then transferred to a nylon
membrane and probed with an rDNA promoter probe (Southern). The
chromatin immunoprecipitation (ChIP) antibodies are indicated above
the gel by letters described in (A). A DNA size marker is shown on the
left. The DNA fragments detected by the probe are indicated with an
arrow on the right. C, Basonuclin’s association with three regions of
rDNA was investigated with ChIP-PCR. The top panel depicts a generic
rDNA transcription unit. Indicated are the promoters, the rRNA coding
sequences (18S and 28S), the external and internal transcribed spacers
(ETS and ITS) as well as the intergenic spacer (IGS). Regions tested by
PCR are indicated with a (*). Twice-ChIP-precipitated DNAs were used as
template for PCR, whose products were analyzed by electrophoresis
(lower panel). The ChIP antibodies are indicated above the gel (B, U, G,
as in A, Ip, Input DNA). PCR specificity is shown on the right. D,
Basonuclin level in HaCaT cells cultured in the presence (+) and absence
(-) of serum. Basonuclin was immunoprecipitated from cell lysate and
analyzed by Western blot. The precipitation antibodies are indicated
above the gel image and the Western detecting antibodies on the left.
E, The association of basonuclin and UBF to rDNA promoter in the
presence and absence of serum. ChIP-precipitated DNA was used as
templates for PCR detection of the rDNA promoter. ChIP-antibodies are
listed to the left of gel image.
doi:10.1371/journal.pone.0000902.g001
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siRNA (siCb-s) did not affect basonuclin level. Thus, we created
a basonuclin knocked-down model in the HaCaT cells.
Knocking-down basonuclin reduced the level of 47S
pre-rRNA at a higher cell density
To investigate basonuclin’s role in rRNA synthesis, we monitored
the level of precursor rRNA (47S) during the time course of siRNA
transfection. HaCaT cells were divided into three groups and
transfected with siBnc1-s, siCb-s (control) and mock (i.e.,
Lipofectamine only) at a cell density of 1.5610
5/35 mm dish
(the density unit, cell per 35 mm dish, will not be shown hereafter).
RT-PCR analysis of total RNA showed that compared with siCb-
and mock-transfected cells, the amount of 47S pre-rRNA did not
change in siBnc1-s transfected cells at 12, 24 and 36 hours post-
transfection (Fig. 2C), when basonuclin protein level was barely
detectable (Fig. 2A). Only at 48 hours post-transfection, a signif-
icant decrease in pre-rRNA level in siBnc1-s transfected cells was
observed. This result was confirmed by Northern analysis, which
showed a 3-5-fold decrease of 47S pre-rRNA at 48 h post-
transfection (Fig. 2C). The Northern analysis also revealed
a decrease of 47S pre-rRNA in the control groups (i.e., siCb-s
and mock transfection) at the 48 h, which was not obvious in the
RT-PCR assay. This decrease suggested a general decline in pre-
rRNA synthesis at the end of the observation period, which was
Figure 2. Inhibition of basonuclin expression via siRNA reduces pre-rRNA level in the HaCaT cells. A, HaCaT cells were transfected with siRNA and
controls. b, siBnc1 targeting siRNA, c, control siRNA, f, mock transfection (Lipofectamin only). Basonuclin mRNA and protein levels were monitored by
PCR and Western blot at four post-transfection time points, 12, 24, 36 and 48 hours. No difference among the experimental groups was detected at
0 h (not shown). A beta-actin RT-PCR served as a control for the quantity and quality (integrity) of RNA. A protein band detected by Brilliant Blue R
(B.B.R) was chosen as a loading control because of its consistent quantity in cells receiving different treatments. The protein levels shown in the
Western blot were quantified in relation to the loading control (histogram). B, Immunocytochemical staining of transfected cells. HaCaT cells were
cultured in chamber slides and transfected with siBnc1-s and siCb-s. Cells were fixed at 48 h post-transfection and stained with anti-basonuclin (anti-
Bnc1) and anti-UBF antibodies simultaneously. Microscopic photographs in each column represent the same field, visualized by different secondary
antibodies, basonuclin, red (cy5), UBF (FITC) and DNA (DAPI). C, Effect of basonuclin siRNA on the level of 47S pre-rRNA. 47S pre-rRNA was measured
by RT-PCR or Northern analysis, with beta-actin and mature rRNA as references, respectively. HaCaT cells were seeded at 1.5610
5 cell/35 mm dish and
transfected after cells were attached. RNAs were prepared at post-transfection 12, 24, 36 and 48 hours. The treatment groups b, c, and f are as
described in (A). The results of Northern analysis was quantified in relation to methylene-green-stained mature rRNA (histogram), n=3. Note that
a reduction of 47S pre-rRNA level was seen only at 48 h post-transfection. M.G., methylene green. D, The effect of basonuclin knock-down could be
seen only at high cell density. 47S pre-rRNA level was monitored by Northern analysis. HaCaT cells were seeded at densities: low, 2610
4, medium,
5610
4 (performed once hence not shown) and high, 1.5610
5 and RNA harvested at 48 h post-transfection. The relative level of 47S pre-rRNA to
mature rRNA was quantified (histogram) (n=2). Mock transfection was not performed in every experiment, hence its omission from the quantitative
analysis.
doi:10.1371/journal.pone.0000902.g002
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proliferation (at approximately 4.5610
5). To verify this notion, the
effect of siBnc1-s was tested at three seeding cell densities, i.e., low,
2610
4; medium, 5610
4; and high, 1.5610
5. These seeding
densities produced cell densities mimicking that at 12, 36 and
48 hours post transfection (RNA harvest) when 1.5610
5 seeding
density was used (Fig. 2D). Indeed, Northern analysis confirmed
that under normal culture conditions, 47S pre-rRNA synthesis was
down-regulated (4–5 fold) when HaCaT culture reached a higher
density (Fig. 2D). This density-dependent rRNA regulation was
consistent with previous observations in 3T6 cells [14]. Further-
more, it verified that only at a higher cell density, the rRNA
synthesis reduction in basonuclin-deficient cells could be observed.
These results suggested that quantitatively, the rRNA synthesis
controlled by basonuclin was minor compared with the massive
synthesis required for cell proliferation. Because basonuclin’s role
in rRNA synthesis could only be observed at a higher cell density,
all further analyses (e.g., IP or ChIP) were carried out at a high cell
density of 4,5610
5.
Basonuclin co-precipitated with a Pol I subunit
To understand basonuclin’s role in rRNA synthesis regulation, we
investigated its association with subunits of Pol I (RPA194 and
RPA116). Basonuclin was likely an rRNA transcription regulator,
but its relation to Pol I had not been ascertained previously. Cell
extract was prepared from HaCaT cells cultured to a density of
4.5610
5 and analyzed by immunoprecipitation with antibodies
against basonuclin, UBF, RPA194 and RPA116 (Fig. 3A). Anti-
basonuclin antibodies precipitated a complex, which contained
RPA194 and RPA116, but not UBF (Fig. 3A). The amount of
RPA194 and RPA116 precipitated by anti-basonuclin antibody
was less than a similar precipitation with anti-RPA194 and anti-
RPA116 antibodies (Fig. 3A), suggesting that only a fraction of
precipitable Pol I subunits was associated with basonuclin. This
notion was also supported by the reciprocal precipitation, in
which, anti-RPA194 and anti-RPA116 antibodies precipitated
complexes containing basonuclin (Fig. 3A). The amounts of
basonuclin co-precipitated with RPA194 and RPA116 were also
low compared with that precipitated directly by the anti-
basonuclin antibody (Fig. 3A, left panel), suggesting that not all
basonuclin was associated with these Pol I subunits. These
observations were consistent with the notion that basonuclin also
had a role in regulating Pol II-mediated transcription [10].
Interestingly, UBF did not precipitate with basonuclin, or
basonuclin with UBF (Fig. 3A), suggesting that under the
extraction conditions, the two proteins did not form a stable
complex. On the other hand, under this condition, UBF was co-
precipitated with RPA194 and RPA116, suggesting a more stable
interaction. This study provided the first evidence of interaction
between basonuclin and Pol I. It also suggested that a sub-
population of basonuclin were associated with a sub-population of
Pol I and UBF did not stably interact with this basonuclin-Pol I
complex.
To investigate if basonuclin-RPA194 complex interacted with
rDNA promoter, we examined, via ChIP, whether knocking down
basonuclin would affect RPA194’s association with the rDNA
promoters. HaCaT cells were transfected with siBnc1-s and
treated with formaldehyde at a cell density of 4.5610
5 (48 h post
transfection). The siRNA treatment reduced basonuclin protein
level to below detection but did not affect the levels of RPA194 or
UBF (Fig. 3B, Western). ChIP-PCR analysis showed that
knocking-down basonuclin reduced the association of RPA194
to rDNA promoter, but not that of UBF. In the absence of
basonuclin, rDNA promoter associated with RPA194 was reduced
by approximately 25%, which agreed with our observation in
basonuclin-deficiency oocytes [6]. This result supported the notion
that basonuclin-RPA194 complex was associated with rDNA
promoter and was consistent with the reduced level of 47S pre-
rRNA in basonuclin-knock-down HaCaT cells at this cell density
(Fig. 2C, D).
Basonuclin-associated rDNA promoter was
hypomethylated
The transcription activity of rDNA had been shown to correlate
with DNA methylation within the promoter (for a recent review,
[15]). We investigated, by an Hpa II sensitivity assay and by
bisulfite sequencing, if basonuclin- and UBF-associated rDNA
promoters were differentially methylated. ChIP DNAs were
digested with either Hpa II (methylation sensitive) or its
isoschizomer, Msp I (CpG methylation insensitive), and the
digested DNAs were used as templates for PCR amplification of
the promoter region. Hpa II sensitivity assay showed that both
basonuclin- and UBF-associated promoters were hypomethylated
(Fig. 4A). The same assay also showed that approximately one
Figure 3. Basonuclin is associated with RPA194 and RPA116, subunits
of Pol I. A, Immunoprecipitations detected a basonuclin-RPA194/
RPA116 complex. Immunoprecipitations (IP) were performed with
extract of HaCaT cells cultured to a high density and analyzed by
Western blots. The IP antibodies are indicated above the gel image and
that used for Western blots on the left. B, Basonuclin-deficiency reduces
the association of RPA194 and rDNA promoter. Basonuclin was
knocked-down in HaCaT cells by siRNA and the cells were analyzed
by Western for protein levels and by ChIP for association of various
factors to rDNA promoter. The Western (upper panel) showed that
basonuclin level was reduced to below detection by treatment of
siBnc1-s, but the level of RPA194 and UBF was not affected. The lower
panel shows the results of PCR analysis of the amount of rDNA
promoter precipitated by ChIP. The siRNA reagents the same as
indicated in the upper panel. The Western and ChIP antibodies are
indicated on the left. C, A quantification of rDNA promoter precipitated
by anti-RPA194 in the presence and absence of basonuclin. Shown are
qPCR results normalized to the rDNA quantity in the presence of
basonuclin. An asterisk indicates p,0.05 (n=3).
doi:10.1371/journal.pone.0000902.g003
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reported previously [16]. In mouse, the critical methylation site,
which abolished UBF binding to the promoter, was identified to be
the cytosine at 2133 [17]. In human, there was also a CpG at
2132, which overlapped with the high-affinity binding site of
basonuclin (Fig. 4B). Bisulfite sequencing confirmed the overall
hypomethylation status of both basonuclin- and UBF-associated
promoters (Fig. 4B). It also showed that the CpG at 2132 was not
methylated. These results supported the notion that basonuclin
was associated with actively transcribed rDNA.
HaCaT rDNA promoters contain single nucleotide
polymorphisms with promoter-specific distribution
The hypothesis that basonuclin and UBF resided in different
RPA194/RPA116 complexes predicted that they were not
associated with the same rDNA promoter at the same time. To
test this hypothesis and to characterize basonuclin- and UBF-
associated rDNA promoters, basonuclin-, UBF-, and RPA194-
associated chromatins were purified in two-rounds of immuno-
precipitation from HaCaT cells. rDNA promoter (2248 to +100)
was PCR-amplified from the precipitated chromatin and cloned.
Randomly picked clones were sequenced. Sequence analysis
showed several consistent variations between the HaCaT rDNA
promoter and the human rDNA promoter sequence in the
GenBank (Accession No. U13369). For our analysis, these
variations were uninformative because of their ubiquitous presence
in all cloned HaCaT rDNA promoters. Therefore, a consensus
sequence of HaCaT rDNA promoter was derived from 181
individual promoter sequences (Fig. 5A). This consensus sequence
served as a baseline for identifying single nucleotide polymorph-
isms (SNP) in rDNA promoters associated with basonuclin, UBF
and RPA194. Of the 181 clones sequenced, 106 contained SNPs.
An additional 10 clones contained only small deletions and
insertions, which were all in the transcribed sequence and hence
not included for the SNP analysis. Overall, there were 167 SNPs in
the 106 clones, but no SNP was consistently associated with
promoters precipitated by a particular antibody (ChIP group)
(Fig. 5B). The SNP frequencies in promoters precipitated by
various antibodies differed (Fig. 5B, histogram); however, the
differences were not statistically significant (Table 1). Next, we
divided the promoter into seven 50-base regions and examined the
regional SNP distribution within each ChIP group (Fig. 5B, C).
The SNP frequency of each region was scored and cross-
compared with other regions within the same promoter. These
regional SNP frequencies showed characteristic differences in
promoters associated with RPA194, basonuclin and UBF, but not
in the control (input)(Fig. 5C). For example, in basonuclin-
associated promoters, ,20.0% of SNPs (10/49) were found in
between nucleotides 2100 to 251 (Fig. 5C, region d), which was
Figure 4. Basonuclin-associated rDNA promoter is hypomethylated. The DNA methylation status of basonuclin-associated rDNA promoter was
analyzed by the HpaII/MspI sensitivity assay (A) and by bisulfite sequencing (B). A, A PCR analysis of the integrity of the rDNA promoter after HpaII or
MspI digestion. The source of PCR templates is indicated above the gel image, and the treatment received by the templates, below. c, control
template (genomic DNA), w, templates were incubated in water, b, in restriction buffer, H, with HpaII, M, with MspI. B, Depicted on top is the region
of rDNA amplified by the PCR shown in A. Transcription start site is indicated as a bent arrow and the cis-elements are depicted as gray segments.
HpaII/MspI sites are shown as banners and CpG sites, diamond-headed pins. Cytosine at position 2132 is marked with a red hallo. The regions of
basonuclin and UBF DNase I footprints are indicated by color-coded bars above the DNA. Listed below are DNA sequences from the region in
between 2180 to 2126. The reference (U13369) and HaCaT rDNA promoter consensus sequences (the first two lines, respectively) are shown as they
are sequenced after bisulfite treatment; i.e., all CpGs (in red) are assumed to be methylated and the rest of the Cs are converted to Ts due to the
bisulfite treatment. The rest nine sequences are actual bisulfite sequencing data from five UBF-associated promoters and four basonuclin-associated
promoters. The presence of a T (in blue) in the CpG position signifies that the CpG was not methylated.
doi:10.1371/journal.pone.0000902.g004
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PLoS ONE | www.plosone.org 5 September 2007 | Issue 9 | e902Figure 5. Single nucleotide polymorphism (SNP) in HaCaT rDNA promoters. A, A consensus DNA sequence of HaCaT cell rDNA promoters. The
consensus (in bold letters) was deduced from the sequence of 181 HaCaT rDNA promoter clones, which were obtained from PCR-amplified rDNA
promoters. Twenty-one of the clones were obtained directly from genomic DNA, the rest were isolated from ChIP DNA precipitated by anti-
basonuclin (49 clones), anti-UBF (44 clones), anti-RFA194 in the presence (44 clones) and absence of basonuclin (23 clones). A human rDNA promoter
sequence (U13369) is listed below the HaCaT consensus. The two sequences are aligned according to their transcription start site (+1). B, A tabulation
of SNPs in various ChIP groups. A generic rDNA promoter is depicted at the top with transcription start site (bent arrow), and the cis elements (dark
gray boxes) indicated. UCE, up-stream control element and CORE, the core element. Nucleotide coordinates are shown below the DNA. The three
basonuclin binding sites (light gray boxes labeled A, B, C) are indicated. SNPs are depicted as dots. The horizontal position of each dot indicates its
location in the rDNA promoter, and its vertical position, the ChIP groups as indicated on the left. Input, a collection of randomly picked genomic
rDNA promoters, Bnc1-, UBF- and RPA194- (Pol I) associated promoters; Pol I/siBnc1, RPA194-associated promoters in basonuclin-deficient cells. Not
all clones contained SNP and the percentage of SNP-containing clones in each ChIP group is shown by a histogram on the right. For a statistical
analysis of the SNP frequency, see Table 1. C, For analyzing the regional SNP variations, the promoter is divided into seven 50-base non-overlapping
regions, which were named alphabetically, as indicated at the bottom of (B), a, 2250 to 2201, b, 200 to 149, etc. The regional SNP frequencies are
plotted for the input and three ChIP groups, RPA194, UBF and Bnc1. Statistically significant differences are indicated (*, p,0.05).
doi:10.1371/journal.pone.0000902.g005
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promoter. More interestingly, in the same region of rDNA
promoters isolated from genomic DNA (input), no SNP (0/21) was
present. Similarly, in UBF-associated promoters, the same region
contained only one SNP (1/44 or 2.3%), and this value was
significantly different from that of the basonuclin-associated
promoter (p,0.05) (Fig. 5C). This analysis strongly suggested
that regional SNP frequency was transcription-factor-specific.
Basonuclin and UBF were associated with different
subsets of rDNA promoters
To explore further the characteristic SNP distributions among the
ChIP groups, we scanned the promoter region to score SNPs using
several ‘‘window’’ sizes (i.e., 40, 50, 60, 100 bases). The scanning
approach avoided the potential bias in dividing the promoters in
non-overlapping regions. The window size smaller than 40 was not
used because it might not contain sufficient number of SNPs for
statistical analysis. To scan, the 50-base window was shifted in one
nucleotide increment. The SNP scores were expressed as the ratio
of SNP/(SNP+non-SNP) for each window size and plotted in
alignment with the promoter sequence, using the center nucleotide
to register each window (Fig. 6A). A prominent feature of
basonuclin and UBF promoters was the low SNP frequency in the
windows centered on the transcription start site (TSS, arrow in
Fig. 6B), which was consistent with the importance of this
sequence to rRNA transcription [18–20].
A chi-square (362) test was used to compare the SNP
frequencies between the promoters (Fig. 6C). The null hypothesis
was that the SNP frequency was random and not related to the
promoter type. The chi-square tests showed that for all window
sizes (i.e., 40, 50, 60 and 100 bases), the results were similar, and
the larger the window size, the lower the resolution. We report
here the results obtained with a window size of 50 bases. The chi-
square tests showed that generally, for approximately two thirds of
nucleotide positions (i.e., between windows centered at 2245 to
2100 in the promoter, as well as between windows centered at
+10 to +100 in the transcribed region), the null hypothesis was
accepted (Fig. 6, 7, 8, grey regions above the red line). However,
the tests also revealed that in windows centered at 2100 to +10,
the null-hypothesis was rejected (p,0.05) in various chi-square
testings, which meant that regional SNP frequencies were indeed
related to transcription factor/promoter interaction (Fig. 6C and
7). As mentioned earlier, basonuclin-associated promoters showed
a higher SNP frequency than that associated with UBF in between
nucleotides 2100 to 251. The chi-square test confirmed this
conclusion by showing that the two types of promoters differed in
windows centered at 294 to 265, and pinpoint the difference to
be centered within basonuclin binding site B (Fig. 6C).
Similarly, compared with randomly picked rDNA promoters
(input), basonuclin-associated promoters showed a significantly
higher SNP frequency in windows centered at 268 to 256
(Fig. 7B, input/Bnc1). On the other hand, compared with the
input, the UBF-associated promoters showed a significantly lower
SNP frequency in windows centered at 27t o+2, and a higher
SNP frequency in windows centered at 277 (Fig. 7C). Re-
markably, these characteristic SNP distributions of basonuclin-
and UBF-associated promoters were reflected in the RPA194-
associated rDNA promoters, which showed a significantly lower
SNP frequency around the TSS (210 to +20) and a higher
frequency between windows centered at 220 to 270 (Fig. 7D,
input/Pol I). These analyses strongly suggested that basonuclin
and UBF were associated with different subsets of rDNA
promoters, and both sets of promoters were associated with
RPA194.
We also analyzed the effect of basonuclin-deficiency on
promoters associated with RPA194 (Fig. 8). Promoters associated
with RPA194 showed a characteristic SNP distribution, in which
a high SNPs frequency was detected in between 250 to 210
(Fig. 8B). Knocking down basonuclin clearly modified this
distribution. This modification was consistent with the reduction
of RPA194’s association with rDNA promoter in basonuclin-
deficient HaCaT cells (Fig. 3B), for such reduction would change
Table 1. P values of pair-wise comparison of SNP frequency in
rDNA promoters obtained from ChIP assays.
......................................................................
Input Bnc1 UBF RPA194 RPA194 w/o Bnc1
Input 0.957 0.214 0.828 0.592
Bnc1 0.128 0.834 0.492
UBF 0.200 0.060
RPA194 0.400
Nomenclatures are as described in Fig. 5.
doi:10.1371/journal.pone.0000902.t001
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Figure 6. A comparison of the local SNP frequencies in rDNA
promoters. A, Depicted is a generic rDNA promoter, to which graphs in
B and C are aligned. B, The frequency of SNP was scored by scanning
the promoter sequence with a 50-base window. The scores are
expressed as the ratio of SNP/(SNP+non-SNP). Each SNP score is
aligned to A, using the center nucleotide of each window. Shown are
SNP scores of three promoter sets: Bnc1, UBF and the input. An arrow
indicates the low SNP frequency near the transcription start site in
basonuclin- and UBF-associated promoters, but not in the input. In C,
a series of pair-wise chi-square tests were performed on the
corresponding SNP frequencies of basonuclin- and UBF-associated
promoters. The resulting p values are plotted in alignment with A and
B. As a reference, the positions of cis-elements as well as basonuclin
binding sites are shown at the bottom of panel B.
doi:10.1371/journal.pone.0000902.g006
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the reduction of SNP frequency in the region (250 to 270) was
also consistent with the loss of promoters associated with
basonuclin, which had a higher SNP frequency in this region
(Fig. 6B and Fig. 8B, arrow pointing down). This reduction was
accompanied by an increase in SNP frequency around 220 to +20
(Fig. 8A, arrow pointing up), including TSS, suggesting that this
increase was not due to an increase in the proportion of UBF-
associated promoter, which had a low SNP frequency 220 to +1
(Fig. 6A). In basonuclin-deficient HaCaT cells, the most
prominent change in RPA194-associated promoters was an
increase in SNPs upstream the promoter, in the region between
2170 and 2120. This change might be brought about by
promoters previously not associated with RPA194.
DISCUSSION
We present evidence that basonuclin is associated with rDNA
promoter in vivo. We demonstrate this point in HaCaT cells by
ChIP assays. Similar results were obtained with mouse testicular
cells, using an independent anti-mouse basonuclin antibody
(Zhang and Tseng unpublished), which will be reported elsewhere.
Our mapping experiment suggests that basonuclin is mainly
associated with the promoter of rDNA, and to a lesser extend, with
the ITS-1, but not with IGS. This distribution is different from
that of UBF [13], but similar to that of c-Myc [21]. The
interaction of basonuclin and rDNA promoter is likely functional
because knocking down basonuclin in HaCaT cells reduces both
RPA194’s association with rDNA promoter and the amount of
47S pre-rRNA. Similarly, we showed previously that knocking
down basonuclin in mouse oocytes reduced the number of Pol I
transcription foci [6].
Our immunoprecipitation study provides the first evidence of
a protein complex containing basonuclin, RPA194 and RPA116,
but not UBF. Furthermore, only a fraction of precipitable RPA194
and RPA116 is pulled down by the anti-basonuclin antibody. This
observation is supported by the result that knocking-down
basonuclin partially reduces RPA194’s association with rDNA
promoter but does not affect that of UBF. We were not able to
knock-down nucleolar UBF via siRNA (Zhang and Tseng,
unpublished), which preclude the experiment examining how
Figure 7. A statistical pair-wise comparison of local SNP frequency
between the randomly picked genomic rDNA promoter and the
promoters associated with basonuclin, UBF, or RPA194. A, a generic
rDNA promoter, to which all the other panels (B, C, D) are aligned. The
notations on the rDNA promoter are as described in Fig. 5A. In panel B,
C, D, p values were calculated by a chi-square test and plotted. The
notation and graphic depictions are as described in Fig. 5B. B, input vs.
basonuclin, C, input vs. UBF, D, input vs. RPA194.
doi:10.1371/journal.pone.0000902.g007
Figure 8. A comparison of RPA194-associated promoters in the
presence and absence of basonuclin. A, A generic rDNA promoter is
depicted as described in Fig. 5. B, SNP frequencies of RPA194-
associated promoters are plotted as described in Fig. 5. Arrows show
the region as well as the direction of changes caused by basonuclin-
deficiency. C, Pair-wise chi-square tests on SNP frequencies shown in B
were performed. The resulting p values are plotted in alignment with
panels in A and B. The notations are as described in Fig. 4 and 5.
doi:10.1371/journal.pone.0000902.g008
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promoters. The notion that basonuclin forms complex with
a fraction of Pol I is also supported by the magnitude of reduction
in pre-rRNA level caused by basonuclin-deficiency. This reduction
is smaller compared with proliferation-related rRNA synthesis.
These observations suggest that (i) proliferation-related rRNA
synthesis, which is regulated via UBF, TIF-1A/Rrn3p, Rb and
a number of other factors [14,22–31], is dominant during cell
cycle; (ii) the rRNA synthesis that requires basonuclin becomes
significant after the down regulation of proliferation-related
synthesis when keratinocytes become quiescent.
Our previous observation suggested that basonuclin regulates
a subset of rDNA [6]. The results discussed above are also
consistent with this notion. Sequence analysis of HaCaT rDNA
promoters precipitated by various antibodies provides additional
support. Mammalian cells possess several hundreds of rDNA
transcription units and little is known about the SNP of their
promoters. Our sequencing data show that rDNA promoters of
HaCaT cells contain numerous SNPs, which are not likely a result
of the standard PCR and cloning artifact, because the same
procedure produced very few SNPs in mouse rDNA promoters
(Zhang and Tseng, unpublished). More likely, these SNPs are
a result of the interplay between random mutation and selection
during the long culture history of HaCaT cells. In other words,
rDNA array in cultured cells does not undergo repair or
homogenization that takes place during meiosis in gametogenesis.
The stochastic origin of SNPs in HaCaT rDNA promoter is
supported by our observation that the distribution of these SNPs is
random in the 59 transcribed region of pre-rRNA, which does not
have a known promoter function, but these distributions show
significant characteristics in regions critical for promoter and
transcription factor function. The most important finding relevant
to our proposal is that the distribution of SNPs suggests that
basonuclin-associated rDNA promoters differ from that associated
with UBF, as well as from a random sampling of genomic rDNA
promoters.
Our study sheds light on several issues in basonuclin research.
The first concerns whether basonuclin and UBF bind to the same
rDNA promoter molecule simultaneous. Previously, DNase I
footprinting showed that in vitro basonuclin interacted with three
highly conserved sites (binding site A, B and C) within human and
mouse ribosomal RNA gene (rDNA) promoters [3–5]. Binding site
A has the highest affinity to basonuclin and overlaps partially with
the footprint of UBF [3–5]. This overlap raises a question if the
two regulators interact with the promoter cooperatively or
competitively [5]. The data presented here favor the notion that
basonuclin and UBF are associated with different rDNA promoter
molecules. This conclusion is supported by the characteristic SNP
distributions within each rDNA promoter, as well as by the
observation that basonuclin and UBF form separate RPA194/
RPA116 complexes. Although our promoter sequence comparison
cannot completely exclude co-existence of basonuclin and UBF on
some promoters, our data strongly suggest that their promoter
preferences differ. It should be pointed out that our data do not
suggest how basonuclin and UBF recognize their own promoter
subsets. We have not detected any consistent sequence features in
the promoter region. The lack of consistent sequence features
precludes a sequence-based recognition. Possibly, regions outside
basonuclin and UBF binding sites, other protein factors,
chromatin structure and epigenetic modifications provide the
basis for discerning the different promoter subsets [15,32]. This
issue warrants future investigation.
Another issue concerns a lack of protein sequence conservation
in basonuclin’s middle pair zinc fingers (zinc fingers 3 and 4)
[10,33]. This lack of evolutionary conservation of middle pair is in
contrast to the high degree of conservation seen in the N-terminal
pair (zinc fingers 1 and 2) and the C-terminal pair (zinc fingers 5
and 6) from fish to human [9]. The interpretation was that zinc
fingers 3 and 4 were not required for sequence-specific DNA
binding. Our analysis supports the interpretation that the
sequence-specificity of the middle pair zinc fingers is relaxed.
The overall random distribution of SNPs in HaCaT rDNA
promoters makes these SNPs a probe for functional constraints on
a DNA sequence (i.e., similar to artificial mutagenesis). If
a promoter region accumulates random SNP, it is likely that the
sequence in that region is not critical for promoter function. It is
therefore unlikely a coincidence that basonuclin binding site B (i.e.,
the middle binding site) accumulates random SNPs, whereas
binding sites A and C have lower SNP frequency (Fig. 5A).
Similarly, the absence of SNP accumulation in the same region
(i.e., 2100 to 260) in the UBF-associated promoters suggests that
the sequence in that region is important for Pol I complex that
contains UBF, though this sequence requirement is unlikely due to
UBF, which binds to a different site [34–36]. Conceivably, another
DNA binding factor in the UBF-Pol I complex interacts with this
region [32]. Therefore, the higher SNP frequency in certain
regions is likely the results of lack of selective pressure for that
region, and is not a requirement for a particular interaction.
The third issue relates to our inability to detect pre-rRNA
changes in basonuclin-deficient oocytes, despite the fact that the
number of Pol I transcription foci was clearly reduced [6]. In light
of our present study, this discrepancy is likely due to the high level
of rRNA transcription in the oocytes, which might mask the small
drop in the 47S pre-rRNA level due to loss of basonuclin. We
encountered that same problem in our HaCaT basonuclin knock-
down model. The massive proliferation-related rRNA synthesis
masked the effect of loss of basonuclin. It was only when
proliferation-related synthesis subsided in a confluent culture, the
amount of rRNA synthesis controlled by basonuclin became
significant. Our study shows an inadequacy in the current method
of assaying rRNA synthesis, which cannot readily detect changes
in the expression of a subset of rDNA.
Although it has been well recognized that different cell types
have distinctive requirement for rRNA synthesis, cell-type specific
regulation has not been well studied [37]. The first cell-type- and
developmental-stage-specific regulatory mechanism for rRNA
synthesis was discovered from studying Xenopus oogenesis
[38,39]. Cell lineage-specific regulation of rRNA synthesis was
noted in a recent report on Runx2 [40]. Runx2 is a member of the
Runt-related transcription factor family, which establishes and
maintains cell identity. Runx2 was shown to repress rRNA
transcription by affecting Pol I complex and local chromatin
modification at the rDNA promoter region. It was proposed that
lineage-specific control of ribosomal biogenesis is a fundamental
function of transcription factors that govern cell fate [40]. Another
study of mouse TIF-1A (a homolog of yeast Rrn3p) also suggested
the existence of yet recognized regulatory pathways for rRNA
synthesis. TIF-1A, a basal Pol I transcription factor, is essential for
rRNA transcription in cultured cells and a key mediator for
proliferation-related regulation of Pol I activity [31,41–43]. It is
therefore surprising that TIF-1A -/- embryo could survive to E9.5
and developed all three germ layers as well as extra-embryonic
tissues [44]. This observation raised an interesting question
regarding rRNA transcription requirement in early embryogeneisis
and the possibility of alternative rRNA synthesis pathways that
differ from the one currently understood. Our results support the
notion that other rRNA synthesis regulatory pathways exist and
suggest that basonuclin is a component of one of these pathways.
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output can be regulated by transcription rate of individual copies,
or the number of copies transcribed. Regulation of the size of
rDNA pool that is actively transcribed has not been well studied
[45]. A particularly interesting feature of cell-type-specific
regulation of rRNA synthesis may relate to the number of rDNA
transcribed [37]. A series of previous cytogenetic studies revealed
that individual rDNA clusters could be regulated independently in
different cell types and in response to serum stimulation [46–48].
These studies concluded that transcription activity is regulated at
the level of single rDNA cluster and transcription rate can be
modulated by activating or repressing individual clusters according
to the metabolic requirements of the cell. In other words, cell-type-
specific regulation of rRNA synthesis involves differential usage of
a subset of rDNA. This notion was re-enforced by a latter study
examining the number of Pol I transcription foci in different
species and cell types [49]. Our data corroborate these early results
that cell-type-specific regulation of rRNA synthesis relates to
differential transcription from subsets of rDNA. Future studies
should focus on understanding the substructure in rDNA array
and on molecular isolation of rDNA transcription units regulated
by cell-type-specific factors.
MATERIALS AND METHODS
Cell culture
HaCat cells were grown on 100 mm-diameter culture dishes in
DMEM supplemented with 10% bovine calf serum at 37uC and
5% CO2. For immunocytochemistry, HaCaT cells were grown on
chamber slides (Nunc Inc., Naperville, IL)
Immunoprecipitation
The anti-human-Bnc1 antibody was described in [3]. The anti-
RFA116 antibody was a generous gift from Ingrid Grummt [24].
Commercial antibodies were obtained from Santa Cruz Bio-
technology Inc. (anti-UBF H-300, sc-9131; anti-RPA194 H-300,
sc-28714; anti-Wilm’s Tumor antigen or WT1 F-6, sc-7385). Cells
were lysed in the RIPA buffer, i.e., 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS, 5 mM EDTA, 0.5 mM phenylmetha-
nesulfonyl fluoride or PMSF, 100 ng/ml protease inhibitor
cocktail from Roche Applied Sciences (Penzberg, Germany) in
16 PBS. Immunoprecipitation was performed as previously
described [10]. Briefly, precleared cell lysates were incubated with
2 mg of antibodies at 4uC overnight, then precipitated with Protein
A Sepharose beads followed by washing with a low sodium
washing buffer, a high sodium washing buffer and 16 PBS.
Immunocomplexes were separated by electrophoresis on a SDS-
polyacrylamide gel (SDS-PAGE).
Knocking down basonuclin by small interfering RNA
Small interfering RNAs (siRNA) and the corresponding negative
controls were designed by a web-based software BLOCK-iT
RNAi Designer (Invitorgen, Carlsbad, CA). The siRNAs are:
Stealth-siRNA (si-Bnc-s) targets human basonuclin sequence at
1220 to 1224: 59-GCCGTCCACTTGAAGATCAAGCATA-39,
Negative control of stealth-siRNA (si-Cb-s):59-GCCACCUUCA-
AGUAGAACCGGUAUA-39. All siRNA reagents were obtained
from Invitrogen.
For transfection, cells were seeded at 1.5610
5/well in a 6-well
plate one day before transfection, and transfected with annealed
siRNA using Lipofectamine 2000 (Invitrogen) in a procedure
recommended by the manufacturer. Cells were harvested at the
indicated post-transfection time for RNA and protein analysis.
Western blotting
Protein samples were electrophoresed on SDS-PAGE and electro-
transferred onto polyvinylidene difluoride (PVDF) membranes
(Immobilon-P, Millipore, Bedford, MA). Each PVDF blot was
incubated with a primary antibody (see Immunoprecipitation for
source) at 4uC overnight. The primary antibodies were visualized
by horseradish peroxidase-conjugated secondary antibodies
(1:10000 dilution) and detected with an ECL Western blotting
system (Amersham Biosciences, Piscataway, NJ). Prestained
molecular weight standards (New England Biolabs, MA) were
used in estimating the apparent molecular weight.
Northern analysis of pre-rRNA
Total RNA was isolated from cultured HaCaT cells using Trizol
reagent (Invitorgen, Carlsbad, CA) at indicated post-transfection
time. Equal amount of RNA from each time point was electro-
phoresed on agarose gel and transferred to a Hybond-N+membrane
(Amersham Biosciences, Piscataway, NJ). The blot was probed with
32P-labeled 59-ETS sequence (the first 300 bp of 47S pre-rRNA).
Immunocytochemistry
Cells were cultured in 2-well chamber slides and fixed by methanol
and acetone as described in [3]. Anti-Bnc1 and anti-UBF
antibodies were diluted in 3% BSA/PBS and incubated with cells
overnight at 4uC. The primary antibodies were visualized by
fluorescently labeled secondary antibodies, i.e., a cy5-labeled goat-
anti-rabbit for Bnc1 or a FITC-labeled goat-anti-mouse for UBF
(sc-3844 and sc-3699, Santa Cruz Biotechnology Inc.). The
antibodies were diluted as instructed by the manufacturer.
Chromatin Immunoprecipitation (ChIP) assay
ChIP was performed as previously described [10]. Briefly, HaCaT
cells were fixed with 1% formaldehyde for 10 minutes at 37uC.
The fixed cells were lysed in the RIPA buffer and sonicated on ice
with an ultrasonic sonicator (Dr. Hielscher UP 100H) at
amplitude=1 and duty cycle=100% in 12 one-minute pulses.
The sonicated cell lysates were precleared with Protein A
Sepharose beads (Amersham Biosciences, Piscataway, NJ) pre-
treated with salmon sperm DNA and BSA. Chromatin was
precipitated by 2 mg of antibodies as indicated. The immuno-
complexes were absorbed with 75 ml of salmon-sperm-DNA- and
BSA-treated Protein A Sepharose beads, and washed for 5 times
with each immunoprecipitation buffer as previously described
[10]. The ChIP was performed once more and immuno
complexes were eluted with 300 ml of elution buffer (1% SDS,
0.1 M NaHCO3). Cross-link was reversed. DNA was extracted by
phenol/chloroform.
ChIP-Southern
DNA eluted from ChIP was linked with a primer (59-TCGACC-
CACGCGTCCG), which served as the priming sites for PCR.
PCR products were separated by electrophoresis on an agarose gel
and transferred to a Hybond-N+membrane. The blot was probed
with
32P-labeled rDNA promoter (2241 to 160).
ChIP-PCR, Cloning and Sequencing
The rDNA promoter (from 2248 to +100 of human rDNA
U13369) was amplified by PCR using the DNA eluted from ChIP
as a template. The primers used in examining the presence of ITS
1 and IGS were those designated H8 and H23/27 in [13].
Standard PCR reactions were performed for 25 cycles following
a 5-minute incubation at 72uC. Each cycle consisted of 30 seconds
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products were cloned into a plasmid (pGEM-T Easy Vector,
Promega, Madison, WI) and sequenced by the DNA Sequencing
Facility in the Department of Genetics at PENN. Bisulfite
sequencing was done with an EZ DNA methylation Kit (ZYMO
Research Co., Orange, CA) following manufacturer’s instructions.
Sequence alignment was first performed by a web-based program
(http://bioinfo.genopole-toulouse.prd.fr/multalin/) [50] and the
machine alignment was then refined manually.
Statistical analysis of SNPs
Three types of analyses were performed. 1) Tests of dependency of
SNP frequencies among ChIP groups in the entire promoter
region (Table 1); 2) tests of dependency of SNPs among non-
overlapping sub-regions of each ChIP group (Fig. 4C); and 3) tests
of dependency of SNP frequencies among ChIP groups by
sampling with a scanning window. For the chi-squared test, the p-
value of independence was computed from 262-contingency
tables (one degree of freedom for Fig. 5, 7 and 8) or from 362-
contigency tables (2-degree of freedom for Fig. 6). For the large
sets of p-values (295 p-values, Fig. 5, 6 and 7), all values were
examined by a q-value program [51] (http://faculty.washington.
edu/jstorey/qvalue/index.html), which calculates a multiple-test
correction. All significant p-values passed the q-value threshold
(False Discovery Rate, FDR) of 0.20.
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